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Introduction
The kidney glomerular filter functions to remove small molecular 
wastes from the blood without the loss of large plasma proteins into 
the urine. The filter is composed of 3 layers: fenestrated endothelial 
cells, the glomerular basement membrane (GBM), and epithelial 
cells known as podocytes (1). The GBM is thought to act as a size- and 
charge-selective filter or gel. On the outer aspect of the GBM, podo-
cytes spread out across capillary loops and form a tight interdigitat-
ing network of membrane extensions known as foot processes. The 
space between adjacent foot processes is covered by a specialized 
cell junction complex that allows the passage of fluid and solutes.
The exact mechanism of glomerular filtration is not com-
pletely understood and has been the subject of modeling studies 
(2–5). All of these models predict that the size selectivity of the 
GBM is not 100% effective and is, to a certain degree, permeable 
to plasma proteins. In an average human, approximately 180 liters 
of blood is filtered by the kidney daily. Even if the GBM filtration 
barrier is 99.9% effective, as predicted by the modeling studies, 
the total volume of blood flow would still result in significant 
amounts of plasma proteins crossing the GBM (~9 grams of albu-
min and ~180 mg of IgG crossing the GBM every 24 hours). Since 
the slit diaphragm is considered impermeable to proteins the size 
of albumin or larger, we postulated that podocytes must have a 
mechanism to handle proteins that have crossed the GBM.
It was proposed over 40 years ago that podocytes internalize 
and remove proteins that cross the GBM (6, 7). Numerous studies 
using electron microscopy have shown increased numbers of pro-
tein-containing vesicles in podocytes under nephrotic conditions in 
which there is significant leakage of proteins across the GBM (8–18). 
Previously, we showed that expression of the neonatal Fc receptor, a 
transcytosis receptor for Ig and albumin, allows podocytes to handle 
these proteins by internalization and transcytosis (19).
Fluid-phase uptake in cells occurs through 2 distinct processes 
(20). Micropinocytosis is a nonspecific process that results in 
small vesicles of less than 0.1 μm in diameter and involves both 
coated and noncoated vesicles (21). A second, more specialized 
process called macropinocytosis only occurs in certain cell types. 
It involves the formation of large vesicles measuring 0.2–5 μm in 
diameter that form at sites of membrane ruffling (22). Macropino-
cytosis is clathrin independent, but requires actin, RAC1, and PI 
3-kinase (PI3K). In certain cells like immature DCs and macro-
phages, macropinocytosis is a constitutive process (23, 24); in 
other cells, it is induced by extracellular stimuli, such as growth 
factors (25). Macropinocytosis allows for efficient internaliza-
tion of extracellular fluids (up to 1 cell volume of fluid/hour), and 
because of the larger size of the vesicles, it is also more efficient for 
the uptake of large-sized molecules.
Here, we discovered that podocytes internalize fluid via mac-
ropinocytosis and that the rate can be increased by free fatty acids 
(FFAs) bound to albumin. Distinct from other known regulators of 
macropinocytosis, we found that lipid-binding GPCRs and Gβ/Gγ 
subunits regulate macropinocytosis in podocytes. Macropinocyto-
sis may function to maintain the GBM by removing proteins that 
cross the GBM. In a proteinuric setting, however, this response 
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the nephrotic mice was not simply the result of more tracers cross-
ing the disrupted GBM and reaching the podocytes; the uptake of 
10 kDa FITC-dextran, which readily passes through intact as well 
as disrupted GBM was also increased during proteinuria (Figure 1, 
D–F). Increased uptake of FITC-albumin and FITC-dextran (data 
not shown) by podocytes also occurred in Adriamycin-treated 
mice, a different model of nephrotic syndrome, as compared with 
that observed in untreated control mice (Figure 1, G and H). These 
results suggested that uptake of extracellular fluid is stimulated in 
podocytes during proteinuria.
Albumin stimulates macropinocytosis in podocytes. To study 
fluid-phase endocytosis in podocytes in vitro, we incubated 
immortalized podocytes in culture with 70 kDa FITC-dextran. In 
the absence of any stimulus, moderate amounts of uptake were 
detected by both immunofluorescence and flow cytometry when 
podocytes were incubated at 37°C, but not at 4°C (Figure 2, A–C). 
To mimic the increased exposure to plasma proteins during pro-
teinuria, we incubated podocytes with highly abundant plasma 
proteins. The addition of BSA dramatically increased the uptake of 
FITC-dextran (Figure 2, A–C). This effect was specific to albumin, 
to FFAs may function as a maladaptive one, leading to podocyte 
dysfunction and death. Loss of albumin during proteinuria and 
the subsequent increase of unbound FFAs have been implicated 
in nephrotic syndrome as an inducer of ANGPTL4 expression 
in podocytes (26). Our work suggests that FFAs may be involved 
in the development of nephrotic syndrome not only by inducing 
ANGPTL4, but also by directly affecting podocytes.
Results
Podocytes are highly endocytotic in vivo. Electron micrographs of 
the kidney often reveal intracellular vesicles in podocytes (8–14). 
Twenty-four hours after injection with fluorescently labeled fluid- 
phase tracers (70 kDa FITC-Ficoll), confocal imaging of the kidney 
glomerulus showed fluorescence labeling, suggesting endocytic 
uptake (Figure 1A). To examine fluid-phase uptake during pro-
teinuria, we carried out similar experiments with a mouse model of 
nephrotic syndrome, the laminin β2-KO (Lamb2–/–) mouse (27–29). 
The uptake of FITC-Ficoll was markedly increased in the Lamb2–/– 
mice and occurred in cells that were labeled with podocin, a podo-
cyte-specific marker (Figure 1, B and C). The increased uptake in 
Figure 1. Podocytes are highly endocytotic in vivo, and endocytosis is stimulated under proteinuric conditions. (A–F) WT or Lamb2–/– mice were injected 
i.v. with 70 kDa FITC-Ficoll (A–C, green) or 10 kDa FITC-dextran (D–F, green). Twenty-four hours after injection, glomerular sections were stained for laminin 
α5 (A, B, D, and E, red) or podocin (C and F, red) and counterstained with Hoechst 33342 (blue). Insets are enlarged images of the indicated areas. (G and 
H) Control or Adriamycin-injected mice were injected i.v. with FITC-albumin (green). Twenty-four hours after injection, glomerular sections were stained for 
podocin (red) and DAPI (blue). Images are representative of at least 3 independent experiments. Original magnification, ×120 (all insets enlarged ×1.8). 
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To assess the level of macropinocytosis in podocytes, we com-
pared podocytes with immature DCs, which are known to exhibit a 
high rate of constitutive macropinocytosis (31). While DCs showed 
higher levels of uptake compared with untreated podocytes, BSA 
induced a rate of macropinocytosis in podocytes that surpassed that 
of DCs (Figure 3C). Macropinocytosis in DCs was not affected by 
BSA, suggesting that regulation of macropinocytosis in podocytes is 
distinct from that in other cell types. Indeed, incubation with EGF 
and PDGF, which are known activators of macropinocytosis (25, 
32), did not stimulate macropinocytosis in podocytes, even though 
downstream targets like ERK were activated (Figure 3D).
FFAs bound to albumin are the stimuli for podocyte macropinocy-
tosis. A major function of albumin is to bind hydrophobic molecules 
(33). In contrast to conventional BSA, FFA-free BSA did not induce 
macropinocytosis (Figure 4A), while lipids isolated from BSA or 
clinical-grade human serum albumin (HSA) stimulated macropino-
cytosis (Figure 4B). This suggested that plasma lipids bound to 
albumin were the causative factors stimulating macropinocytosis.
as the addition of IgG, another abundant plasma protein, did not 
have any effect (Figure 2D). Stimulation of endocytosis was also 
observed in mice injected with BSA (Figure 2, E–H).
Immunofluorescence and electron microscopy revealed that 
the size of the endocytosed vesicles ranged from 0.2 to 0.6 μm 
(Figure 2A), which suggested that the tracers were being endocy-
tosed by macropinocytosis. Macropinocytosis is a specific process 
that can be distinguished from other types of fluid-phase uptake 
by the size of the endocytic vesicles and the ability to internalize 
larger molecules (30). BSA enhanced uptake of high-molecu-
lar-weight fluorescent tracers (500 kDa and 2,000 kDa) (Figure 
3A). Treatment of cells with mannan to inhibit mannose recep-
tor–mediated internalization of dextran did not affect stimulation 
of uptake by BSA (Figure 3A). In addition, inhibition of key com-
ponents of macropinocytosis (aquaporin, PI3K, actin polymeriza-
tion) blocked BSA-stimulated dextran uptake in podocytes (Figure 
3B). These results indicated that the fluid-phase uptake stimulated 
by BSA was mediated by macropinocytosis.
Figure 2. Albumin stimulates fluid-phase uptake in podocytes. (A and B) Cultured podocytes were incubated in the presence of 70 kDa FITC-dextran for 30 
minutes and analyzed by (A) fluorescence microscopy or (B) flow cytometry. Upper inset in (A) is an enlarged image of the indicated area. Lower inset is an 
electron microscopic image of a cultured podocyte incubated with 10% BSA. In A, original magnification of 3 left panels, ×20; far right insets scale bars:  
0.5 μm. (C and D) Podocytes were incubated with BSA or IgG in the presence of 70 kDa FITC-dextran for 30 minutes and analyzed by flow cytometry. Results 
are shown as the fold change in mean fluorescence intensity. Data represent the mean ± SD of 3 independent experiments analyzed by ANOVA, followed by 
Bonferroni’s post-hoc analysis. *P ≤ 0.05. (E) The glomerulus of a mouse injected daily with BSA for 4 days was analyzed by electron microscopy. Arrows indicate 
protein-filled vesicles inside podocytes. (F–H) Control mice or mice given daily injections of BSA for 4 days were injected i.v. with 70 kDa FITC-Ficoll (green). Glo-
merular sections were stained for laminin α5 (F and G, red) or podocin (H, red) and counterstained with Hoechst 33342 (blue). Insets are enlarged images of the 
indicated areas. (E–H) Original magnification, ×120 (insets enlarged ×1.8). Images in A and E–H are representative of at least 3 independent experiments.
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ing on GPCRs. This showed that podocytes express a variety of 
lipid-binding GPCRs, including FFA receptors 1, 2, and 3 (FFAR1, 
FFAR2, and FFAR3) (data not shown). The ligands of FFAR1 are 
medium- and long-chain fatty acids, whereas FFAR2 and FFAR3 
bind to short-chain fatty acids. To determine their roles in podo-
cyte macropinocytosis, we used siRNA or shRNA to knock down 
the expression of these receptors (Figure 5A and Supplemental 
Figure 1A; supplemental material available online with this article; 
doi:10.1172/JCI79641DS1). Lipid-induced macropinocytosis was 
decreased when any one of the FFAR isoforms was reduced (Fig-
ure 5B and Supplemental Figure 1B). Simultaneous knockdown of 
all 3 isoforms led to a further reduction (Figure 5B).
Triggering of GPCRs stimulates the disassembly and activa-
tion of heterotrimeric G proteins composed of the Gα, Gβ, and 
Gγ subunits. Stimulation of podocytes with lipids induced eleva-
tion of cAMP levels, a second messenger known to be regulated 
by GPCRs through Gα signaling (Supplemental Figure 2, A and 
B). However, treatment of podocytes with forskolin (an activator 
of adenylate cyclase) or cAMP analogs had no effect on dextran 
uptake (Supplemental Figure 2C). Furthermore, macropinocyto-
sis was not induced when constitutively active GαS (Q227L) was 
overexpressed (Supplemental Figure 2D). These results indicated 
that cAMP does not mediate the stimulation of macropinocytosis.
The activity in the lipid extracts was resistant to boiling or 
hydrolysis in acid or base (data not shown). Incubating the lipids 
with hydroxylamine (cleavage of ester bonds), methanolic HCl 
(cleavage of ester, glycosidic, and amide bonds), or periodate (oxi-
dation of sugar moieties) also did not significantly reduce activity 
(data not shown).
We tested candidate lipid molecules to identify the active lipid 
compound(s). Initial assays using bioactive lipids (lysophosphat-
idic acid, prostaglandins, lipopolysaccharide, sphingosylphospho-
rylcholine, etc.) or lipids with various polar head groups (choline, 
ethanolamine, n-dansyl-ethanolamine, n-pyrenesulfonyl-ethano-
lamine) did not result in stimulation of macropinocytosis (data not 
shown). However, several different FFAs, including oleic acid, eico-
satrienoic acid (ETA), eicosapentaenoic acid (EPA), and docosa-
hexaenoic acid (DHA) stimulated macropinocytosis in a dose- 
dependent manner (Figure 4C). When combined, the different 
FFAs had an additive effect and induced dextran uptake to levels 
comparable to those in BSA lipid extracts (Figure 4D). Thus, sev-
eral different FFAs can stimulate macropinocytosis in podocytes.
Stimulation of macropinocytosis by albumin-associated FFAs is 
mediated by lipid-binding GPCRs and Gβ. Since many lipids induce 
their effects through specific receptors, we searched podocyte 
expression datasets (34) for expression of lipid receptors, focus-
Figure 3. Albumin-stimulated fluid-phase uptake in podocytes occurs by macropinocytosis. (A) Podocytes were incubated with 70 kDa, 500 kDa, or 
2,000 kDa FITC-dextran in the presence of 7.5% BSA and mannan (1 mg/ml) for 30 minutes and analyzed by flow cytometry. (B) Podocytes were pretreated 
with pCMB (100 μM), wortmannin (1 μM), or cytochalasin D (10 μM) for 30 minutes. The cells were subsequently incubated with 15% BSA and the inhibitors 
in the presence of FITC-dextran for 30 minutes and analyzed by flow cytometry. (C) BM-derived DCs and podocytes were incubated with BSA in the pres-
ence of FITC-dextran for 30 minutes and analyzed by flow cytometry. (D) Podocytes were incubated with EGF (100 nM) and PDGF (25 nM) in the presence 
of FITC-dextran for 30 minutes and analyzed by flow cytometry. Inset is an immunoblot of cells to detect p-ERK, with CD2AP used as a loading control, 
and is representative of 3 independent experiments. All results are shown as the fold change in mean fluorescence intensity. Data represent the  
mean ± SD of 3 independent experiments analyzed by ANOVA, followed by Bonferroni’s post-hoc analysis. *P ≤ 0.05; **P ≤ 0.01.
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cytoskeleton induced by albumin-bound FFAs, we stained podo-
cytes with phalloidin and analyzed them by confocal microscopy. 
Addition of lipids extracted from BSA led to dramatic changes in 
cell morphology, with formation of filopodial structures (Supple-
mental Figure 5A). We noted similar changes after ETA treatment 
(Supplemental Figure 5A).
The Rho GTPases RAC1 and CDC42 are critical regulators of 
the actin cytoskeleton and are key regulators of macropinocytosis. 
To determine whether albumin-associated lipids activate RAC1 
and CDC42, podocytes were transfected with fluorescence reso-
nance energy transfer (FRET) biosensors and analyzed using live 
cell imaging. Albumin-associated lipids rapidly induced activation 
of both RAC1 and CDC42 (Supplemental Figure 5, B and C). Con-
firming the role of RAC1, the addition of a RAC inhibitor attenu-
ated macropinocytosis (Supplemental Figure 5D).
High-fat diet potentiates Adriamycin-induced proteinuria. To 
test the role of FFAs on podocyte function in vivo, we placed mice 
on a high-fat diet (HFD) to increase plasma FFA levels (Figure 
7A). After 8 weeks on the diet, we did not detect significant lev-
els of albuminuria in either control or HFD-fed mice (Figure 7B, 
day 0), suggesting that elevated levels of FFAs by themselves do 
not induce proteinuria in mice. To test whether FFAs could aggra-
vate proteinuria, we injected mice with a low dose of Adriamycin 
to cause podocyte injury. Following Adriamycin administration, 
we noted a significantly higher urine albumin/creatinine ratio 
in HFD-fed mice compared with that in control mice (Figure 7B, 
days 4 and 7). Notably, 2 of 5 HFD-fed mice eventually went on 
In addition to triggering the Gα subunit, GPCR signaling 
induces the release of the Gβ/Gγ complex, which activates its own 
downstream effectors, including PI3K and RAC1 (35). To deter-
mine whether the Gβ/Gγ complex mediates lipid-induced mac-
ropinocytosis, we incubated podocytes with gallein, an inhibitor 
of Gβ. Fluorescein, a compound similar in structure to gallein that 
does not inhibit Gβ, was used as a control. Gallein reduced basal 
and lipid-induced dextran uptake in podocytes (Figure 6A). High 
concentrations of gallein almost completely blocked the stimula-
tion of micropinocytosis by lipids.
These results were confirmed using shRNA to inhibit expres-
sion of Gβ. Expression analysis showed that 2 of the 4 Gβ iso-
forms, Gβ1 and Gβ2, are expressed in cultured podocytes (data 
not shown). Immunoblotting with isoform-specific Abs showed 
a significant reduction of specific Gβ isoforms in Gnb1 and Gnb2 
single-knockdown podocytes (Figure 6B and Supplemental Figure 
3A). Knockdown of either Gnb1 or Gnb2 impaired macropinocy-
tosis induced by lipid (Figure 6C and Supplemental Figure 3B). 
Knockdown was less efficient in the Gnb1/Gnb2 double-knock-
down cells, consistent with the idea that the complete absence 
of Gβ is toxic to the cells (Figure 6B and Supplemental Figure 4). 
Nonetheless, knockdown of both Gβ isoforms further reduced lip-
id-induced macropinocytosis (Figure 6C). This confirms that the 
response to lipids is mediated by Gβ/Gγ subunits.
Albumin-associated FFAs induce changes in actin structures 
and activate RAC1 and CDC42. Macropinosomes are formed at 
sites of membrane ruffling. To analyze the changes in the actin 
Figure 4. Podocyte macropinocytosis is stimulated by albumin-associated FFAs. (A) Podocytes were incubated with 7.5% BSA or FFA-free BSA in the 
presence of FITC-dextran for 30 minutes and analyzed by flow cytometry. (B) Podocytes were incubated with 7.5% BSA, BSA lipid extract, or HSA lipid 
extract in the presence of FITC-dextran for 30 minutes and analyzed by flow cytometry. (C) Podocytes were incubated with increasing concentrations  
(1 or 10 μM) of FFAs in the presence of FITC-dextran for 30 minutes and analyzed by flow cytometry. (D) Podocytes were incubated with individual FFAs  
(2 μM) or a mixture of the FFAs (2 μM each) in the presence of FITC-dextran for 30 minutes and analyzed by flow cytometry. All results are shown as the 
fold change in mean fluorescence intensity. Data represent the mean ± SD of 3 independent experiments analyzed by ANOVA, followed by Bonferroni’s 
post-hoc analysis. *P ≤ 0.05; **P ≤ 0.01.
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to develop severe proteinuria (Figure 7B, day 24) compared with 
none of the control mice. These results suggest that high FFA lev-
els can aggravate podocyte injury and exacerbate proteinuria.
Discussion
Large vesicles within podocytes are often seen by electron micros-
copy in proteinuric kidney diseases (7). There has been much 
speculation about the origin of these vesicles (36–39), but their 
functional significance has remained unresolved. Recent studies 
have demonstrated that impairment of the endocytic machinery 
in podocytes leads to proteinuria, indicating that endocytosis may 
play a crucial role in podocyte function (19, 40, 41). Our results 
reveal that podocytes induce significant levels of macropinocyto-
sis in response to FFAs. FFAs stimulate macropinocytosis through 
a pathway distinct from that in other cell types, one that involves 
FFARs, Gβ/Gγ, and RAC1.
Our results indicate that podocytes are capable of internal-
izing large amounts of extracellular fluid and molecules by mac-
ropinocytosis. Demonstrating whether fluid-phase uptake occurs 
by macropinocytosis is not a straightforward task because of the 
nonspecific nature of its cargo and the lack of signature marker 
proteins. The uptake of large molecules is considered the most 
reliable measure of macropinocytosis. Tracer molecules larger 
than 70 kDa are internalized predominantly by macropinocyto-
sis, since the small size of micropinosomes or endosomes restricts 
both the size and numbers of high molecular weight molecules 
(42). We showed that podocytes were able to efficiently internal-
ize 70 kDa dextran in vivo (Figure 1, A–C) and even larger dextrans 
(up to 2,000 kDa) in vitro (Figure 3A), consistent with macropino-
cytosis. Suppression of uptake by inhibitors of PI3K, aquaporin, 
and actin polymerization further lends support for macropinocy-
tosis as the phenomenon we measured (Figure 3B).
The role of macropinocytosis varies depending on cell type. 
Immature DCs use macropinocytosis as a means of surveying the 
surrounding environment for foreign pathogens (23). In Dictyos-
telium and Ras-transformed cells, macropinocytosis serves as a 
major pathway for nutrient supply (43, 44). In some conditions, 
macropinocytosis is transiently induced by certain stimuli such as 
phorbol esters or growth factors such as EGF or CSF-1 (25, 32, 45).
Our work suggests that macropinocytosis may be involved 
in the removal of plasma proteins that enter and cross the GBM. 
Because the filter is not completely effective, it has been argued 
that an active clearance mechanism must exist to prevent the filter 
from clogging. The high expression of receptors for albumin, IgG, 
and complement on podocytes support the idea that podocytes 
play a specialized role in the uptake and removal of plasma pro-
teins that cross the GBM.
Macropinocytosis may also be a route of nutrient uptake in 
podocytes, similar to Ras-transformed cells (43, 44). Podocytes 
are unique in that they are located wholly in the urinary space 
and are separated from the blood supply by the GBM. This might 
restrict their exposure to nutrients, partially explaining why podo-
cytes exhibit constitutive autophagy and why impairing autoph-
agy is detrimental to podocytes (46, 47). We observed trafficking 
of the macropinosomes to the lysosomes in podocytes (data not 
shown), and it is therefore plausible to speculate that proteins 
internalized via macropinocytosis can be degraded and used as a 
source of energy and anabolic substrates.
It is interesting that FFAs can induce macropinocytosis. FFAs 
have been implicated in a feedback loop that mediates the hyper-
triglyceridemia that accompanies nephrotic syndrome (26). Sig-
nificant urinary loss of albumin decreases the plasma lipid–buff-
ering capacity, leading to elevated levels of unbound FFAs (26). 
It was recently shown that this elevation of FFAs increases circu-
lating ANGPTL4, which inhibits lipoprotein lipase, and thereby 
leads to elevated plasma triglycerides (26). Notably, ANGPTL4 
produced from podocytes induces proteinuria in rats through 
mechanisms that are yet to be elucidated (26, 48). We found 
that FFAs induced ANGPTL4 expression in podocytes (Supple-
mental Figure 6), indicating that FFAs could induce proteinuria 
through ANGPTL4 induction.
Our findings, however, also suggest that FFAs could affect pro-
teinuria by directly altering podocyte function and viability. We 
and others have previously shown that RAC1 activation in podo-
cytes leads to podocyte foot process effacement and proteinuria 
in mice (49, 50). In addition, excessive macropinocytosis and 
accumulation of albumin in podocytes has been shown to induce 
lysosomal dysfunction, podocyte loss, and subsequent glomerulo-
Figure 5. Stimulation of macropinocytosis by albumin-associated lipids is mediated by FFARs. (A) Ffar-knockdown podocytes were analyzed by quantita-
tive PCR. Results are shown as the fold change of mRNA levels compared with those of controls. (B) Control and Ffar-knockdown podocytes were incubated 
with FITC-dextran and BSA lipid extracts for 30 minutes and analyzed by flow cytometry. Results are shown as the fold change in mean fluorescence inten-
sity. Data represent the mean ± SD of 3 independent experiments analyzed by ANOVA, followed by Bonferroni’s post-hoc analysis. *P ≤ 0.05; **P ≤ 0.01.
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sclerosis (15, 16, 51–55). Consistent with this, we found that mice 
with elevated FFA levels were more susceptible to Adriamycin 
and exhibited significantly higher levels of albuminuria (Figure 7). 
The effects of a HFD on the kidney are complex, and there may be 
additional factors that are affecting proteinuria, but the results are 
consistent with a role for FFAs.
It is intriguing to consider the possibility that an interplay 
between FFAs and ANGPTL4 plays a critical role in the transition 
from proteinuria to full-blown nephrotic syndrome. Podocyte injury 
would lead to proteinuria, but the transition to nephrotic syndrome 
might involve the elevation of both plasma FFAs and ANGPTL4. 
The combined effect of albuminuria and hyperlipidemia (caused 
by elevated ANGPTL4) would lead to an increase in the FFA/albu-
min ratio. Once the level of FFAs exceeds the buffering capacity of 
albumin, the FFAs could play a key role in a vicious cycle of persis-
tent albuminuria and podocyte damage that converts proteinuria 
into nephrotic syndrome. In support of this idea, lipoprotein apher-
esis to lower lipid levels reduces proteinuria and improves renal 
function in some patients with nephrotic syndrome (56). While it is 
unclear whether elevated plasma FFAs are sufficient by themselves 
to initiate proteinuria, our work suggests that once proteinuria has 
begun, FFAs can amplify the consequences of proteinuria.
Taken together, we have identified a pathway of inducible 
macropinocytosis in podocytes that may play a role in mainte-
nance of the glomerular filtration barrier. Persistent activation of 
this pathway during proteinuria, however, may have maladaptive 
consequences and lead to nephrotic syndrome. FFAs and FFARs 
are new potential targets for the treatment of nephrotic syndrome.
Methods
Reagents. FITC-Ficoll (70 kDa), FITC-dextran (10, 70, 150, 500, 
2,000 kDa), Adriamycin, BSA, mouse serum IgG, mannan, p-chloro-
mercuriobenzoate (pCMB), wortmannin, cytochalasin D, recombi-
nant EGF, ovalbumin, 8-Br-cAMP, 8-pCPT-2′-O-Me-cAMP, forsko-
lin, 3-isobutyl-1-methylxanthine (IBMX), isoproterenol, fluorescein, 
anti-podocin Ab (catalog P0372), and anti–β-actin Ab (clone AC-15) 
were obtained from Sigma-Aldrich. FFA-free BSA was purchased from 
SeraCare Life Sciences. HSA was purchased from Williams Medical 
Company. Hoechst 33342 and recombinant PDGF was purchased 
from Life Technologies. Anti–phospho-ERK Ab (clone 197G2) was 
obtained from Cell Signaling Technology. Rhodamine B-dextran (70 
kDa) was purchased from Nanocs. Oleic acid, eicosatetraenoic acid, 
eicosapentaenoic acid, and docosahexaenoic acid were obtained from 
Nu-Chek Prep. Gallein and EHT1864 was purchased from Tocris Bio-
science. Anti-Gβ1 (catalog sc-379) and anti-Gβ2 (catalog sc-380) anti-
bodies were purchased from Santa Cruz Biotechnology Inc. Anti–lami-
nin α5 (57) and anti-CD2AP (58) Abs have been previously described.
Mice. All mice were housed in a specific pathogen–free facility at 
Washington University School of Medicine. C57BL/6J, 129/SvJ, and 
BALB/cJ mice were obtained from The Jackson Laboratory. Laminin 
β2–knockout (Lamb2–/–) mice with a muscle-specific rescue transgene 
have been described previously (27–29). For HFD experiments, age- 
and weight-matched male 129/SvJ mice were randomly grouped and 
given a normal chow diet (13 kcal% fat; LabDiet) or a HFD (60 kcal% 
fat, D12492; Research Diets Inc.). After 8 weeks on the diet, mice were 
injected i.v. with Adriamycin (10 mg/kg body weight) or an equal vol-
ume of saline as a control.
Cell culture. Conditionally immortalized podocytes were generated 
as described previously (59) and maintained at 33°C in RPMI1640 sup-
plemented with 10% FBS, 1 mM sodium pyruvate, 10 mM HEPES, 100 
U/ml penicillin, 100 μg/ml streptomycin, 0.1 mM β-mercaptoethanol, 
and 100 U/ml recombinant mouse IFN-γ (a gift of Robert Schreiber, 
Washington University, St. Louis, Missouri, USA).
BM-derived DCs were cultured as previously described (60). 
Briefly, BM cells were cultured in Iscove’s modified Dulbecco’s 
medium (IMDM) supplemented with 10% FBS (Hyclone), 1 mM 
Figure 6. Stimulation of macropinocytosis by albu-
min-associated lipids is mediated by Gβ activation. 
(A) Podocytes were pretreated with 2 or 10 μM 
fluorescein or gallein for 30 minutes. Subsequently, 
the cells were incubated with BSA lipid extract in the 
presence of rhodamine B–dextran for 30 minutes and 
analyzed by flow cytometry. (B) Podocytes expressing 
shRNAs targeting firefly luciferase (fLuc), Gnb1, Gnb2, 
or Gnb1 and Gnb2 (Gnb1/2) were immunoblotted for 
Gβ1 and Gβ2 expression. β-Actin was used as a loading 
control. A representative blot of 3 independent exper-
iments is shown. (C) GNB-knockdown podocytes were 
incubated with BSA lipid extracts in the presence of 
rhodamine B–dextran for 30 minutes and analyzed 
by flow cytometry. Results in A and C are shown as 
the fold change in mean fluorescence intensity. Data 
represent the mean ± SD of 3 independent experi-
ments analyzed by ANOVA, followed by Bonferroni’s 
post-hoc analysis. *P ≤ 0.05
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FACS buffer (2% FBS and 2 mM EDTA in 1× PBS) for 
flow cytometric analysis. FACS data were collected 
on FACSCanto II or LSR II flow cytometers (BD Bio-
sciences) and analyzed with FlowJo software.
Western blots. Podocytes were lysed in a modi-
fied radioimmunoprecipitation assay (RIPA) lysis 
buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 
1 mM EDTA, 1% NP-40, 0.25% sodium deoxy-
cholate, 1 mM PMSF, 1 μg/ml aprotinin, 1 μg/ml 
leupeptin, 1 μg/ml pepstatin, 1 mM Na3VO4, 1 mM 
NaF) for 30 minutes on ice. The protein content of 
the lysates was quantified with a protein assay kit 
(Bio-Rad). Equivalent amounts of each sample were 
separated by SDS-PAGE, transferred to nitrocellu-
lose membranes, and immunoblotted for phospho-
rylated ERK (p-ERK), CD2AP, Gβ1, Gβ2, or β-actin. 
The blots were visualized by ECL or infrared imag-
ing on a LI-COR Odyssey system (LI-COR).
Lipid extraction. Lipids were extracted from BSA or HSA using the 
Bligh-Dyer method with minor modifications. Three milliliters of 20% 
BSA in ddH2O was added to a mixture of 6 ml chloroform and 12 ml 
methanol in a glass tube and mixed on an orbital shaker for 15 minutes 
at room temperature. Chloroform (6 ml) was added to the mixture while 
vortexing at low speeds, followed by 6 ml of 1 M NaCl. The samples were 
centrifuged at 800 g for 5 minutes to separate the aqueous and organic 
phases. The lower organic phase was carefully collected, aliquoted into 
1-ml tubes, evaporated under vacuum, and stored at –80°C.
For endocytosis assays, the lipids were resuspended in 30 μl 
DMSO, and the cells were treated with 1 to 5 μl/ml lipid suspension. 
Assuming loss of 50% of the lipids during extraction, this is esti-
mated to be equivalent to the amount of lipids bound to BSA in a 
0.066% to 0.33% solution.
Gene knockdown and overexpression experiments. ON-TARGETplus 
siRNA targeting FFAR isoforms was purchased from Dharmacon (GE 
Healthcare). Podocytes were transfected with a pool of siRNAs con-
taining 4 individual siRNAs targeting each isoform using the Nucle-
ofector System (Lonza). Transfection efficiency was monitored using 
the siGLO Green Transfection Indicator (GE Healthcare).
Lentiviral constructs containing shRNAs targeting FFAR isoforms, 
Gβ isoforms, and firefly luciferase (control) were generated using the 
pFLRu-YFP lentiviral vector (61). The targeting sequences were: fLuc, 
CCAACCCTATTCTCCTTCT; FFAR1, ATCTTTGCCTTGGCCCAC-
TTTG; FFAR2, CGGTTTGCTACTGATCCGCAAT; FFAR3, ACTG-
GAACTGAAGGTAAAGAAT; GNB1, CATTATCTGTGGTAT CACA; 
GNB2, CATCTGCTCCATCTATAGT. PCR products containing the U6 
promoter followed by the shRNA sequences were cloned into the pFL-
Ru-YFP vector using the XbaI/XhoI site.
For lentivirus production, 293T cells were transfected with the 
lentiviral constructs along with packaging plasmids (pMDLg/pRRE 
and pRSV-Rev) and an envelope plasmid (pMD2.G). Proliferating 
podocytes were infected with supernatants containing lentivirus and 
8 μg/ml protamine sulfate for 24 hours. Cells expressing high levels 
of YFP were sorted on a FACSAria II flow cytometer (BD Biosciences) 
7 days after infection.
To generate podocytes stably expressing constitutively active Gαs, 
cells were transfected with a pcDNA3.1 vector containing GαS (Q227L) 
(a gift of Kun-Liang Guan, UCSD, San Diego, California, USA). Sta-
sodium pyruvate, 10 mM HEPES, 100 U/ml penicillin, 100 μg/ml 
streptomycin, 0.1 mM β-mercaptoethanol, and 100 ng/ml recombi-
nant granulocyte macrophage colony-stimulating factor (rGM-CSF) 
(R&D Systems) for 8 days.
Electron microscopy. Slices of kidney cortex or podocytes cultured 
on coverslips were fixed overnight in 4% paraformaldehyde (PFA) and 
4% glutaraldehyde in 0.1 M sodium cacodylate buffer followed by 
repeated washes in PBS. After postfixation in 1% osmium tetraoxide, 
the samples were reduced with 1.5% potassium ferrocyanide for 1 hour 
at 4°C. Subsequently, the samples were washed, dehydrated in graded 
alcohol, and embedded in resin according to standard protocols.
In vivo endocytosis. WT or Lamb2–/– mice were injected i.v. with a 
bolus of FITC-Ficoll (70 kDa) or FITC-dextran (10 kDa) in 0.9% NaCl 
at a dose of 250 mg/kg of body weight. BALB/cJ mice were injected i.v. 
with Adriamycin (10 mg/kg body weight) or an equal volume of saline 
as a control. Six days after the Adriamycin injection, the mice were 
injected i.v. with FITC-labeled albumin (250 mg/kg body weight). 
For BSA injection experiments, mice (C57BL/6J and 129/SvJ mixed 
background) were given a daily i.p. injection of endotoxin-free BSA (15 
mg/g body weight in PBS) for 4 days. On day 4, the mice were injected 
i.v. with 70 kDa FITC-dextran (250 mg/kg body weight). Twenty-four 
hours after injection of FITC-labeled tracers, kidneys were harvested 
from mice, embedded in OCT (VWR International), and snap-frozen 
in methylbutane cooled in a dry ice ethanol bath. Cryosections (8 μm) 
were applied to charged slides using a cryostat.
For immunofluorescence assays, the kidney sections were fixed 
with 1% PFA in PBS for 5 minutes, followed by blocking and perme-
abilization with 2% FBS in PBS with 0.1% saponin. The slides were 
incubated with Abs against laminin α5 or podocin for 1 hour at room 
temperature, followed by extensive washing. Fluorescently conju-
gated secondary Abs were then applied for 1 hour at room temper-
ature. After several washes, the slides were imaged on an Olympus 
FV1000 confocal microscope.
In vitro macropinocytosis assays. Mouse podocytes in 6-well plates 
were serum starved with serum-free RPMI for 2 hours. The cells were 
then incubated in RPMI supplemented with 0.5 mg/ml FITC- or rho-
damine B–dextran for 30 minutes on ice or at 37°C. The cells were 
subsequently washed 3 times with ice-cold PBS and fixed with 4%PFA 
for confocal microscopic analysis or trypsinized and resuspended in 
Figure 7. Mice fed a HFD are more susceptible to Adriamycin-induced proteinuria. Mice were 
given either a normal diet or a HFD. (A) After 8 weeks, serum was collected and analyzed by 
ELISA for FFA and albumin concentrations. (B) Mice were then given a single i.v. injection 
of Adriamycin (10 mg/kg). Urine was collected periodically after injection and analyzed for 
albumin/creatinine ratios. n = 3, normal diet; n = 5, HFD. Samples were compared using the 
Student’s t test (A) or ANOVA, followed by Bonferroni’s post-hoc analysis (B). *P ≤ 0.05.
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Statistics. Data are presented as the mean ± SD. We determined 
significance by ANOVA or a 2-tailed Student’s t test as indicated in the 
figure legends. ANOVA, followed by Bonferroni’s post-hoc analysis, was 
used to determine significant differences in experiments with 3 or more 
samples. A P value of 0.05 or less was considered statistically significant.
Study approval. Animal care and experiments were conducted in 
accordance with protocols approved by the Animal Studies Commit-
tee of Washington University (protocol number 20120013), in compli-
ance with the Animal Welfare Act.
Acknowledgments
This research was supported by the Howard Hughes Medical Insti-
tute; NIH grants R01DK058366 (to A.S. Shaw) and RO1HL118639 
(to R.W. Gross); the German Research Foundation (CRC 992 and 
CRC 1140, Heisenberg-Professorship, to T.B. Huber); the Euro-
pean Research Council; and the Excellence Initiative of the Ger-
man Federal and State Governments (EXC 294, to T.B. Huber).
Address correspondence to: Andrey Shaw, Department of Pathol-
ogy and Immunology, Box 8118, Washington University School of 
Medicine, 660 South Euclid, Saint Louis, Missouri 63110, USA. 
Phone: 314.362.4614; E-mail: ashaw@wustl.edu.
bly transfected cells were selected by serial passage in 400 μg/ml 
G418 for 1 week.
cAMP FRET assays. A pcDNA3 plasmid containing the FRET-
based cAMP biosensor TEpacVV was a gift of Kees Jalink (The Neth-
erlands Cancer Institute, Amsterdam, The Netherlands). Cultured 
podocytes were transfected with TEpacVV using the Nucleofector Sys-
tem and seeded on glass-bottom dishes (MatTek Corp.). Images were 
obtained using an Olympus FV1000 confocal microscope in a temper-
ature-controlled chamber (37°C). The cells were excited at 440 nm, 
and donor and acceptor emission was detected simultaneously using 
a 510 nm beamsplitter and 2 photomultipliers with optical filters: 
465–495 nm (CFP) and 535 to 565 nm (YFP).
FRET measurements were quantified using ImageJ software 
(NIH) and the Ratio Plus plugin. After regions were drawn around 
individual cells, emission ratios were obtained by calculating FRET 
intensities divided by donor intensities. Time-course ratio measure-
ments were normalized to baseline values before stimulation. The 
FRET value was set at 1 at the onset of the experiment.
FFA, albumin, and creatinine assays. Mouse serum and urine sam-
ples were collected at the indicated time points. FFA (BioVision), albu-
min (Bethyl Laboratories Inc.), and creatinine (BioAssay Systems) levels 
were quantified by ELISA according to the manufacturers’ instructions.
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